Setterwalls has advised Flerie in connection with listing on Nasdaq Stockholm

Setterwalls has advised Flerie AB in connection with the listing of the company’s ordinary shares on Nasdaq Stockholm. The trading in Flerie’s ordinary shares on Nasdaq Stockholm commenced on 27 June 2024.

Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. Flerie invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access.